Building Baltimore biotech from research to startup
Blackbird Laboratories is an independent, nonprofit life sciences incubator dedicated to transforming academic discoveries into scalable, venture-ready biotech companies. We are committed to advancing a better future for patients in need of ground-breaking therapies.
What we do
life science incubator
We transform academic discoveries into scalable, venture-ready biotech companies through operational support, founder-facing resources, and strategic capital
accelerating Baltimore biotech
As a nonprofit biotech incubator, Blackbird Laboratories serves as a company-creation engine supporting scientists, building new ventures, and attracting top-tier talent
building from research to startup
Blackbird Laboratories collaborates with scientists from world-class institutions, and early-stage founders in the greater Baltimore region, to transform innovative research into life-changing medicines through company creation. We are dedicated to advancing a better future for patients in need of cutting-edge therapies.
Representative Projects
Our vision is to catalyze a thriving entrepreneurial biotech and life sciences ecosystem in Baltimore by supporting startup formation and development. Our goal is to commercialize transformational science and technologies by evaluating and propelling programs with our collaborators into companies.
Small Molecule Therapeutics for Comprehensive Treatment of Schizophrenia (SCZ)
- Neuronal receptor modulators to rebalance neurocircuitry in SCZ and synchronously treat the broad spectrum of SCZ symptoms.
- Program advancement supported by multifaceted biological discovery and validation platform.
- In collaboration with the Lieber Institute for Brain Development (JHU).
Gut-targeted Therapeutics for Crohn’s and Colitis
- Inhibitors of GCPII to dampen inflammation and ultimately reverse the course of disease in Crohn’s and colitis.
- Rationally designed to have durable tissue-restricted action in the gut.
- In collaboration with Prof. Barbara Slusher (JHU).
Patient-First Digital Clinical Trial Navigation Platform
- Digital platform to inform about clinical trial opportunities, help navigate their complex landscape, and aid clinical trial enrollment.
- Empowering patients, providers, and clinical investigators.
- In collaboration with Prof. Evan Lipson (JHU), Dr. Govind Warrier (JHU), and 1104Health.
Precision Gene Therapy Platform Technology
- Platform technology bringing new capabilities to the field of gene therapies by enabling cell-type-specific transgene expression.
- Empowering existing gene therapy programs through improved safety and efficacy profiles and facilitating implementation of new therapies that were previously not feasible.
- In collaboration with Prof. Jon Ling (JHU)
Collaborators & Partners
Blackbird BioHub
Anchoring innovation in Baltimore
Lorem ipsum dolor sit amet*, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu.
Latest news
- |
Endpoints News Exclusive:
- |
Baltimore Business Journal:
Help us build
Baltimore Biotech
Interested in learning more about Blackbird Laboratories or getting involved? Contact us today and help us advance life sciences research in Baltimore.